New FDA Drug for Diabetes Eye Condition
Health Day News The U.S. Food and Drug Administration on March, 2015Â approved the use of Eylea, an injected drug, to treat diabetic retinopathy in patients with diabetic macular edema. According to the U.S. Centers for Disease Control and Prevention, diabetic retinopathy is a leading cause of blindness in American adults. A third of those over […]
New FDA Drug for Diabetes Eye Condition Read More »
